A Report on Non-Ionizing Radiation

University of Oxford: Microwave News Article Archive (2004 - )

March 8, 2024

“‘Tumor Treating Fields’ Delivered via EM Induction Have Varied Effects Across Glioma Cell Lines and Electric Field Amplitudes,” American Journal of Cancer Research, February 28, 2024. “In summary, we have illustrated that the impact of Tumor Treating Fields can yield highly diverse effects on gene expression within distinct GBM stem cell lines.” Open access.

February 16, 2022

David Robert Grimes is a “got lemons, make lemonade” kind of guy. Or as his famous Irish countryman Oscar Wilde quipped more than 100 years ago, “a grapefruit is just a lemon that saw an opportunity and took advantage of it.”

Well, actually, though that line is attributed to Wilde on countless websites, he never said or wrote it. The first documented use was more than a decade after he died in Paris in 1900. But given so, it seems all the more appropriate to mention it in the context of the Grimes affair.

I bring all this up because I’m still trying to understand why JAMA Oncology would have commissioned or accepted a manuscript on a hotly controversial subject —a review of radiofrequency (RF) radiation and cancer— by a junior Irish academic-cum-columnist without any relevant qualifications, David Robert Grimes, at the time of Dublin City University.

January 18, 2022

Dear Dr. Phil Fontanarosa,

As you are already keenly aware, on December 9th, JAMA Oncology, part of the AMA family of journals, published what purports to be a review of radiofrequency (RF) radiation and cancer by David Robert Grimes.

Grimes’s paper is rife with distortions and omissions. It is a disservice to the AMA and to all those who care about public health. I urge you, as the current editor-in-chief of all AMA journals, to retract this paper.

Here are four reasons why you should set the record straight as soon as possible...

March 30, 2004

A prospective epidemiological study —the first of its kind— has failed to find an association between a woman’s melatonin level and her risk of developing breast cancer. Ruth Travis and coworkers at the University of Oxford in the U.K. report in the March 17 issue of the Journal of the National Cancer Institute that, while they cannot rule out a “moderate” association, their results are a setback for the hypothesis that “endogenous melatonin concentration is a major factor in breast cancer etiology. ”

Subscribe to University of Oxford: Microwave News Article Archive (2004 - )